Kumaraswami Lab

1091

Citations

20

h-index

About the Lab

The Kumaraswami laboratory aims to elucidate the molecular basis of cellular processes that are critical for streptococcal pathophysiology and to use that knowledge to develop novel translational strategies to combat bacterial infections.


Bacterial pathogens survive in complex host environments where they encounter commensal microbial communities and host immune molecules. They engage in interactions with the resident microbiota and host immune effectors during infection. These inter-bacterial and host-pathogen interactions significantly impact the colonization of pathogens and bacterial disease pathogenesis. We are interested in understanding the molecular details and consequences of these interactions in disease pathogenesis. We employ a wide range of tools, including microbiology, biochemistry, structural biology, and animal infection studies to elucidate the molecular mechanisms of bacterial pathogenesis. We are also interested in extending our basic research findings into translational studies to identify novel therapeutic and prophylactic interference strategies to treat or prevent bacterial infections. Two major areas of focus include 1) the role of bacterial intercellular communication in virulence, and 2) the role of bacterial adaptive responses to metal limitation in host-pathogen interactions and bacterial pathogenesis. 

 

Pathology News
There’s a New Strep in Town
New study highlights the complexity of human infections caused by a rapidly emerging strep subtype
Improving Vaccine Design with an AI Booster

CEPI awards $34 million to the Houston Methodist Research Institute-led consortium to use artificial intelligence for the design of vaccines to fight diseases with pandemic potential.

Omicron – Ongoing Lessons in a Pandemic

Omicron Demonstrates the Power and Necessity of Genetic Sequencing in a Pandemic

Researchers Uncover Distinct Patterns of a Common Pathology in Dementia

Known as LATE, a very common form of brain pathology affects ~40% of elderly patients. Researchers at Houston Methodist have unraveled several patterns of LATE in the brains of aging and demented patients. These patterns have distinct clinical, pathologic and genetic associations.

Fighting a Deadly Duo
Investigating therapeutics to fight deadly TB/HIV coinfections.
Houston Methodist and Purdue University Make a Breakthrough That May Result in a More Effective Tuberculosis Vaccine

A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now